Analyzing lung cancer samples to improve diagnosis and treatment
Pathology & Genomics
This study is all about improving how we diagnose and treat lung cancer by looking closely at lung cancer samples and their genetic makeup, so we can help patients get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10891402 on NIH RePORTER |
What this research studies
This research focuses on providing advanced analytic services for lung cancer samples, which includes everything from initial sample handling to detailed microscopic analysis by certified pathologists. The project aims to enhance the diagnosis and treatment selection for patients with various types of lung cancer through comprehensive molecular genetic and genomic analysis. By utilizing both standard clinical pathology services and innovative technologies, the research seeks to deepen the understanding of lung cancer biology and improve patient management. This work supports ongoing research into the genetic mutations that influence lung cancer, which are critical for developing effective treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lung cancer who are seeking advanced diagnostic and treatment options.
Not a fit: Patients with lung cancer who are not eligible for genetic testing or those with non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment options for lung cancer patients.
How similar studies have performed: Previous research has shown significant success in using similar approaches to improve lung cancer diagnosis and treatment, establishing a foundation for this ongoing work.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Barbie, David a — Dana-Farber Cancer Inst
- Study coordinator: Barbie, David a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.